Wright State University

CORE Scholar
Master of Public Health Program Student
Publications

Master of Public Health Program

2009

Benefit Design of Medicare Drug Plans: An Analysis of Ohio and
the National Landscape from 2006 through 2009
Brad Haverkos
Wright State University - Main Campus

Follow this and additional works at: https://corescholar.libraries.wright.edu/mph
Part of the Community Health and Preventive Medicine Commons

Repository Citation
Haverkos, B. (2009). Benefit Design of Medicare Drug Plans: An Analysis of Ohio and the National
Landscape from 2006 through 2009. Wright State University, Dayton, Ohio.

This Master's Culminating Experience is brought to you for free and open access by the Master of Public Health
Program at CORE Scholar. It has been accepted for inclusion in Master of Public Health Program Student
Publications by an authorized administrator of CORE Scholar. For more information, please contact librarycorescholar@wright.edu.

PDP Landscape

1

Benefit Design of Medicare Drug Plans:
An Analysis of Ohio and the National Landscape from 2006 through 2009
Brad Haverkos
Wright State University

PDP Landscape

2

Acknowledgements
A special thanks to Dr. John McAlearney, my committee chair for this project, for all his
help and encouragement. I would also like to thank Dr. Peter Wong and Sylvia Ellison for their
time and assistance in this project. Without the support and help provided from them along with
everyone at the Center for Global Health Systems, Management, and Policy this project would
not have been possible.

PDP Landscape

3
Table of Contents

Abstract ............................................................................................................................................4
Introduction......................................................................................................................................5
Background ......................................................................................................................................6
Literature..........................................................................................................................................8
Methods..........................................................................................................................................17
Results............................................................................................................................................18
Discussion ......................................................................................................................................22
Limitations .....................................................................................................................................27
Conclusions....................................................................................................................................28
References......................................................................................................................................30
Appendix........................................................................................................................................34
Table 1 ..................................................................................................................................34
Table 2 ..................................................................................................................................34
Table 3 ..................................................................................................................................35
Table 4 ..................................................................................................................................36
Table 5 ..................................................................................................................................36
Table 6 ..................................................................................................................................36
Table 7 ..................................................................................................................................37
Table 8 ..................................................................................................................................37
Table 9 ..................................................................................................................................37
Table 10 ................................................................................................................................38
Table 11 ................................................................................................................................38
Table 12 ................................................................................................................................38
Table 13 ................................................................................................................................39
Table 14 ................................................................................................................................39
Figure 1 .................................................................................................................................40
Glossary ................................................................................................................................41
Public Health Competencies Achieved .................................................................................42

PDP Landscape

4
Abstract

Objectives: Since previous research was fragmented and incomplete, I described changes in the
benefit designs of stand-alone PDPs in the United States from 2006 through 2009. In addition, I
identified trends in the PDP market of Ohio and compared them to the national data. The intent
was to discover changes that might only be observed during the examination of a smaller market.
I then presented the enrollment data of stand-alone PDPs in Ohio and discussed the benefit
designs of popular plans to help further understand the PDP market dynamics.
Methods: Each year, CMS collected and released information on benefit characteristics of standalone PDPs in November 2005, November 2006, September 2007, and September 2008. In this
research, I reported on the number of PDPs available (dependent variable) in Ohio and the
United States and the benefit characteristics of those PDPs (independent variables). I provided
summary statistics on the following independent variables: type of benefit, LIS, premium,
deductible, and gap coverage. Additionally, I highlighted the enrollment of PDPs and the benefit
characteristics of those PDPs.
Results: I found that from 2006 to 2009, the benefit characteristics of PDPs in Ohio compared to
national data were similar across all variables. Though PDP availability peaked in 2007, there
remained a greater number of PDPs available in 2009 than there had been in 2006. Meanwhile,
from 2006 to 2009, there was a gradual decline in plans available for low-income-subsidy. The
average premium increased every year from 2006 to 2009. In 2009, the unweighted average of
PDPs in Ohio was $44.33, while the average premium of the most popular PDPs was $32.47.
From 2006 to 2009, there was an increase in PDPs offering more coverage during the gap,
although, in Ohio, none of the most popular plans offered gap coverage. Gap coverage is defined
by CMS as the period of time in which Part D enrollees were responsible for the full cost of their
prescription medications drugs until they qualified for catastrophic coverage.
Conclusions: Results indicate that in 2009, PDP availability for beneficiaries who voluntarily
chose their plan was greater than at any previous time. Additionally, disproportionate to the
amount of plans offered, individuals enrolled in PDPs offering low premiums and PDPs without
gap coverage. As well, a relatively small number of PDPs available nationwide dominated the
market share. Research suggests possible policy changes in Part D concerning cost, benefit
design, and availability.
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Introduction

The Medicare Modernization Act of 2003 (MMA) established a voluntary prescription
drug benefit program known as Medicare Part D for individuals eligible to receive Medicare
services. Beginning in January 2006, those eligible for Part D had the opportunity to enroll via
stand-alone prescription drug plans (PDPs) or Medicare Advantage prescription drug plans.1
Both of these privately sponsored prescription drug plans offered varying benefit designs so long
as the plans met certain standard benefits established through the Centers for Medicare and
Medicaid Services (CMS). The rationale behind this system, in which beneficiaries chose from
on average greater than forty PDPs, revolved around principles of capitalism. Ostensibly, the
market would drive down overall cost, and individual choice would drive which plan types
endured. Ultimately, market demand would serve to simplify Medicare Part D by driving down
the number of plan offerings, while simultaneously leaving the best plans available to
beneficiaries (McClellan, 2006).
According to The Columbia Encyclopedia (2008), private ownership of wealth provides
the basis of capitalism. Theoretically in a pure “laissez-fare” capitalist model, government plays
no role in economic affairs and competition, allowing supply and demand to operate unabated. In
actuality, however, the economic and political philosophies and practices of most contemporary
nations created capitalistic economies containing government intervention (The Columbia
Encyclopedia, 2008). According to many economists, health care goods and services do not
follow typical supply and demand curves, suggesting that health care should not exist under a
pure capitalistic model (Cutler, 2004; Phelps, 2003; The Columbia Encyclopedia, 2008).

1

Medicare Advantage plans included prescription drug coverage along with other standard
health insurance benefits included within Medicare Parts A and B.
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Previously conducted epidemiologic studies examined benefit design utilizing only
national data, and due to limitations in data availability and study design these previous reports
have been fragmented and noncomprehensive. The present research study addressed these
limitations by focusing on PDPs in Ohio and compared benefit characteristics of them to national
data. By principally examining the smaller state level market, significant changes and trends in
benefit offerings should have been more readily apparent and more quickly identifiable. Broadly,
the objective of the primary research was to identify if and how market forces affected PDP
availability and benefit characteristics.
Background
In 2008, the most recent year for which full reporting data is available, national Medicare
Part D enrollment included 44.2 million Medicare beneficiaries, of which, 25.4 million (57%)
enrolled in Part D. 11.2 million (25%) enrolled in stand-alone PDPs, 6.2 million (14%) were dual
eligibles, and 8.0 million (18%) were in MA-PD plans (Kaiser Family Foundation [KFF],
2008).2 Individuals enrolled in stand-alone PDPs had the opportunity to self-enroll on an annual
basis, though some beneficiaries opted to allow CMS to randomly choose a plan for them. In
Ohio, approximately 30% of the 1.8 million Medicare beneficiaries enrolled in stand-alone PDPs
in 2008.
The voluntary self-enrollment process provided beneficiaries the option to enroll in a
stand-alone PDP, a MA-PD plan, or a plan from another source that maintained a minimum
standard coverage established by CMS (also known as creditable coverage).3 CMS enrolled dual
eligibles as well as other low-income beneficiaries who did not choose a plan of their own, into a

2

Dual eligibles were beneficiaries eligible for both Medicare and Medicaid.
If beneficiaries choose not to enroll, they faced a permanent penalty equal to 1% of the national average monthly
premium for each month they delayed enrollment (KFF, 2008).

3
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randomly selected pre-approved low-income subsidy (LIS) PDP. These beneficiaries then had
the opportunity to change to a different LIS PDP at any time during their enrollment.
The Rational Choice Theory provides the basic tenants behind Medicare Part D. Rational
Choice Theory postulates that greater numbers of varied choices benefit consumers by increasing
the likelihood that a utility maximizing choice is available for selection and procurement. This
theory does indicate several necessary conditions that must be met for consumers to benefit from
more choice. These assumptions include consumers having sufficient information about their
available alternatives, having the ability to sift through alternatives to reach a rational and utilitymaximizing decision, and not regretting their choice (Scott, 2000). However, research conducted
beginning in 2006 subsequent to the initiation of Medicare Part D found that many beneficiaries
were unhappy with both the enrollment process and their ensuing choice of PDP (Dulio, Perry, &
Cubanski, 2007). Thus, arguably, Part D does not meet the necessary suppositions for The
Rational Choice Theory. In fact, throughout the last forty years numerous psychologists opposed
this theory and its applicability in various settings (Iyengar, Huberman, & Jiang, 2004).
Previous studies about choice examined the relationship between the number of choices
available to consumers regarding their 401(k) retirement plans and the decision to invest or not
to invest in a 401(k) retirement plan. They revealed the existence of an inverse relationship;
those consumers who faced a greater number of investment options tended to choose the less
profitable investment option of those offered (Iyengar, Huberman, & Jiang, 2004). Though the
applicability of 401(k) plans to PDPs may be debatable the underlying principles are clearly
relevant to the present discussion. Thus, the results of these previous studies extended to PDPs
suggest that a prescription drug program within which consumers often do not explore their plan
options and frequently have regrets about their ultimate choice of PDP provides for an
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unfavorable background for The Rational Choice Theory (Cummings, Rice, & Hanoch, 2008).
This research on choice highlights an overall limitation in the process by which Americans
choose health insurance.
As a solution, after the enactment of Medicare Part D, researchers suggested that the
simplification and standardization of Medicare Part D could improve the process by creating an
environment where beneficiaries would more easily choose a utility maximizing option. By this
rationale, Medicare Part D could then operate optimally under the Rational Choice Theory. This
subsequent literature review highlights pertinent research on the simplification and
standardization of Medicare Part D along with research specific to stand alone PDPs.
Literature
Research on stand-alone PDPs was mostly cross-sectional and speculative in nature.
Additionally, there were no published studies examining enrollment in PDPs nor were there any
studies that used inferential statistics to evaluate benefit characteristics of Part D plans. Studies
used descriptive statistics alone to identify trends from 2006 to 2008. Other studies obtained
information through surveys. These surveys described beneficiaries’ experiences from 2006 and
early 2007 and provided the only research that drew attention to beneficiaries’ ability to choose
an optimal plan. There was no research that specifically addressed the effect of the private PDP
market. Furthermore, research specific to individual states did not exist. In summary, no research
was able to provide a major conclusion or trend about the PDP market. In general, Medicare Part
D intended to lower costs, improve efficiency, and increase access to prescription medications.
Understandably then, there was an abundance of research in business and health care that
focused on the cost effectiveness of the program and out-of-pocket expenditures. These studies,
while noteworthy, were not the focus of this current research. The purpose of this research was to
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identify trends in the availability of stand-alone PDPs, which would help contribute to
understanding the direction of Medicare Part D and the effect of the private market on Medicare
Part D. This current study could further implicate methods to improve the voluntary selfenrollment process.
In 2006, beneficiaries had concerns about the enrollment process questioning how to
enroll, who to call or trust for help enrolling, and even if they wanted to enroll (Kaiser Family
Foundation [KFF], 2006). After two years of the program, participants indicated a general level
of contentment, but a significant majority of these individuals also reported the program was too
complicated (Dulio, Perry, & Cubanski, 2007). Psychological theory suggests that when
individuals have more than ten choices they are more attracted to the initial decision making
process, enjoy the process of choosing more, and have greater satisfaction in their choice as
compared to individuals that choose amongst less than ten options. When examining these
individuals’ choices, research showed that they made a better decision when faced with fewer
options (Iyengar & Lepper, 2000). With regards to Medicare Part D, this research suggested that
there was not a relationship between beneficiaries’ initial satisfaction and the actual quality of
their PDP.
Hibbard, Slovic, and Peters (2000) found that consumers’ skill in using comparative data
to make choices declined with age. Their research showed that the majority of individuals over
65 years of age had difficulty correctly interpreting even simple displays of Medicare health plan
information, and many seniors demonstrated high error rates in accurately using information to
make informed choices on health plan options (Hibbard, Slovic, and Peters, et al., 2000). While,
vulnerable populations were the greatest risk for choosing sub-optimal health plans given their
low levels of health literacy (Hall, Kurth, & Moore, 2007). Despite the fact that many
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beneficiaries had a poor understanding of the plans, most beneficiaries cited that they did not
seek help in choosing a plan. Surveys showed that only a few beneficiaries spent much time
contemplating their choices, and most beneficiary counselors observed that beneficiaries focused
solely on the differences in monthly premiums, rather than any of the other benefit
characteristics (Gold, Achman, & Brown, 2003).
Surveys found the amount of information beneficiaries received was overwhelming, and
beneficiaries frequently cited an inability to sort through the volume of information to make
informed and rational decisions (Hibbard & Peters, 2003). Mobley, McCormack, and Wang
(2005) found the increasing number of plans and unnecessary variations further complicated the
health plan decision-making process for beneficiaries. This suggested that beneficiaries needed
more help in interpreting this information to find the utility maximizing choice. One solution
included further standardizing and simplifying Part D to maximize health literacy (Hoadley,
2008). A study by the Medicare Payment Advisory Commission (MedPAC) in 2004 found
individuals more likely to make a choice when offered a limited array of six choices rather than
when faced with an array of 24 to 30 choices. Surveys noted that somewhere between 65 and 80
percent of individuals believed that Medicare Part D was too complicated (Cummings & Rice,
2008; KFF, 2006; Winter, Balza, Caro et al., 2006). Since the institution of the program in 2006,
these percentages changed minimally.
The continued high uptake rates of this voluntary program demonstrated seniors’ desire
for a prescription drug plan, but as shown in the research many beneficiaries wanted reform of
the program. The Commonwealth Fund (2006) stated that 88% of individuals agreed that “plans
should be required to use the same terms to describe the same benefits,” and three-fourths
agreed, “Benefits should be more standardized to reduce the variation among plans.” More than
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two thirds suggested that the government should simplify the number of Part D plans (Cummings
& Rice, 2008). From these findings it seems clear that beneficiaries had difficulty selecting an
optimal plan. Nevertheless, beneficiaries who went through the process once had no interest in
doing it again, thus demonstrating beneficiaries’ reluctance to change plans once enrolled (Dulio,
Perry, & Cubanski, 2007). Other beneficiaries felt they were already in the best available plan
and therefore had no need to change plans. Those same individuals believed switching to a
different plan would not improve their coverage, because they thought all plans were essentially
the same (Dulio, Perry, & Cubanski, 2007). These findings were concerning and warranted a
close look at possible modifications to the process. Many researchers, including Frank and
Newhouse (2007) concluded that simplification would result in more effective consumer choice
and a more competitive system.
Limited knowledge was a problem for Medicare in 1965 and was similarly a shortcoming
of Part D (Hibbard, Greene, & Tusler, 2006; Sing, Stevens, Cook et al., 2001). Consumer Union
found that an inexpensive plan in 2007 was often more expensive the following year, sometimes
by more than $1000. This was not often easily detectable, as premiums did not necessarily rise,
consequently making it difficult for consumers to understand the cost burden of their plan.
Domino, Stearns, Norton, and Yeh in 2008 reported that during a 1-year period 43% of
beneficiaries could have saved money by switching to a different plan. On average, these
individuals paid $500 more by not switching to a different plan. In spite of this, two national
studies found that at most, only 10% of PDP beneficiaries planned to switch coverage during
open enrollment (Campbell & Morgan, 2007; Domino, Stearns, Norton, & Yeh, 2008).
Additionally, Hsu, Fung, Price et al. (2008) estimated that only 40% of beneficiaries were aware
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that their drug plan included a coverage gap. These studies raised serious questions about
beneficiaries’ knowledge of their PDP and the corresponding benefit costs.
In summary, a sizeable, consistent amount of research justified simplification and
standardization of Medicare Part D, but this research had limitations. The major limitation of
survey data is that it relies on self-report. Questions of validity, reliability, poor memory, and
misunderstanding of the questions are all shortcomings of self-reported surveys. In addition,
there could be a selection bias in the individuals that choose to respond to a survey. Additionally,
surveys are descriptive, not explanatory, and therefore cannot offer any insights into cause-andeffect relationships. On the contrary, surveys are useful in situations where one is interested in
collecting data on aspects of behavior that are difficult to observe directly. They provide a
descriptive analysis of a large number of opinions, because researchers are capable of surveying
large numbers of individuals due to the ease of distribution. Lastly, considering most of the Part
D surveys were from 2006 or early 2007 after only one full year of the program, it is possible the
data was out-dated.
Against Standardization and Simplification
As mentioned, surveyed beneficiaries frequently claimed general contentment with the
program. Without looking further into the complexity of this finding, many policymakers
concluded that changes in Part D were unnecessary. Other than this survey finding, arguments
against standardization and simplification come from expert opinion. The opposing theory to
standardizing and simplifying Medicare Part D through governmental involvement was that the
market unabated would simplify and standardize to the extent needed. In theory, individuals
chose PDPs that resulted in the least amount of out of pocket spending and in doing so chose
their individual optimal plan. This process would drive out unnecessary and unneeded plans, as a
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result simplifying Part D. Similarly, the market would undergo standardization when consumers
demanded it. Other health policy experts were absolutely against standardization, believing that
plan flexibility was the key factor in driving down program costs (Hoadley, 2008).
Some Medicare administrators pointed out market forces have already started to drive
towards simplification (McClellan, 2006). One example was the increase in use of specialty tiers
after the programs first year (Hoadley, 2008). Further evidence included plans creating
innovative approaches to drug coverage during the gap (Hargrave, 2008). Also, in response to
beneficiaries enrolling in fewer plans with standard benefit design, the market offered more
PDPs with enhanced benefit designs. An additional argument from experts suggested that
waiting to standardize the benefit design would provide more time to closely examine the
preferences that beneficiaries reveal when selecting plans (Hoadley, 2008).
In defense of policymakers, individuals have commonly noted general contentment with
individual plans. This, in combination with individual reluctance to change PDPs, provided the
illusion that individuals chose optimal plans, were generally happy with their plans, and did not
feel it necessary to change plans. Even as recently as 2009, the Pharmaceutical Research and
Manufacturers of America (PhRMA) noted that the competitive market approach to the Medicare
drug benefit worked well as it was saving beneficiaries and taxpayers more than expected
(Carey, 2009).
The major limitations to the arguments against standardization and simplification
included unreliable survey data and a lack of data to back-up expert opinion. In fact, most of the
arguments against standardization and simplification were based solely on theories. For these
theories to be legitimate, the basic constructs and assumptions of the theories must be valid and
verified, and as shown, previous studies casted doubt upon many of these assumptions. Since
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previous studies already insinuated that beneficiaries were not choosing their optimal plan, this
present study will not further evaluate this supposition. Specifically, this present study
highlighted changes and trends in the benefit characteristics of plans since 2006. Overall, it
aimed to provide a broad view of the stand-alone market’s response to consumer demand. The
information discovered in this current study provided further data to reinforce or refute
invalidated expert opinions.
Stand-alone PDPs
While there was a significant amount of research on Medicare Part D, only one major
group of researchers focused on stand-alone PDPs. Since 2006, Kaiser Family Foundation (KFF)
produced numerous reports on benefit design and enrollment. In addition, Hoadley, Hargrave et
al. published a report comparing benefit designs in 2006 and 2007.
Since 2006, the number of stand-alone PDPs increased in the United States. The number
of PDPs increased by 30% from 2006 to 2007, from 1,429 to 1,875. Every state noted an
increase. Alaska, Arkansas, and Ohio had the largest increases (Hoadley, Hargrave et al., 2006).4
In 2008, there were 1,824 stand-alone PDPs followed by 1,689 in 2009 (KFF, 2008). In
November of 2007, KFF estimated that sponsors serving almost all regions of the country offer
85% of all stand-alone PDPs (Hoadley, Hargrave et al., 2006). In addition, the market appeared
dominated by a small number of organizations where 15 organizations represent 88% of all PDPs
(Hoadley, Hargrave et al., 2007).
The benefit design of PDPs was either basic or enhanced. The basic plan offered a
standard benefit design established by CMS annually. Enhanced plans offered a benefit design

4

Alaska, Arkansas and Ohio each increased by 18 PDPs from 2006 top 2007.
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that surpassed CMS’ minimum benefit requirements.5 Plans offering enhanced benefits increased
from 43% in 2006 to 47% in 2007 while only accounting for around 17% of enrollees in 2006.
Basic plans increased from 9% in 2006 to 12% in 2007. Low-income subsidy eligible plans
carried more than three-fourths of enrollment in 2006, while only constituting 28.6% of PDPs
(Hoadley, Hargrave et al., 2006). In 2009, approximately half of enrollees were in LIS PDPs
with about a quarter of stand-alone PDPs qualifying as LIS-eligible (Hoadley, Hargrave, &
Cubanski, 2008).
The major benefit characteristics included were premium variability, deductible
variability, and type of coverage in the gap. In 2006, the majority of individuals (48%) enrolled
in plans with premiums between $20 and $30, dissimilar to the distribution of plans offering
premiums from $20 to $30 accounting for 22% of plans (Hoadley, Hargrave et al., 2006). The
weighted average monthly premium in 2006 was $25.93 and climbed steadily since then to the
projected total of $37.29 in 2009. In 2009, premiums ranged from $10.30 to $136.80, a contrast
to 2006 where only one plan had a monthly premium more than $100 (Hoadley, Thompson et al.,
2008).
The standard deductible, as established by CMS, rose annually from $250 in 2006 to
$295 in 2009. The number of PDPs available that offer the standard deductible, less than the
standard deductible, or no deductible remained relatively unchanged from 2006 to 2007. Since
2006, the number of plans offering no deductible continued to stay around 60%, while the
proportion of plans offering the standard deductible remained at about a third (Hoadley,
Hargrave et al., 2006). In 2009, 45% of PDPs charged a deductible with 34% charging the

5

A proportion of these enhanced plans were actuarially equivalent to basic plans. CMS established a standard
benefit design annually. CMS allowed sponsors to offer PDPs that were actuarially equivalent to the basic plans.
Sponsors could also offer PDPs with an increase in benefits. CMS determined what benefits were actuarially
equivalent. One can obtain these actuary tables through CMS.
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standard amount. On the other hand, the percentages of plans that offer some type of gap
coverage increased slightly since 2006 from 15% to around 30% in 2008 but have since dropped
back down to 25% in 2009 (KFF, 2008).6
However, there were several limitations to these reports. For one, the data was all crosssectional in nature. As a result, there were no cause-and-effect inferences. Also, these data
reports used descriptive statistics alone, rather than making any correlative or inferential
conclusions. Lastly, the cross-sectional data on stand-alone PDPs both nationally and locally was
scattered among many different reports from 2006 through 2009 making the data collection
process tedious and lengthy. Fortunately, Hoadley et al. published a report near the end of 2006
combining 2006 and 2007 data, but since then, no reports have been as cumulative or
comprehensive. This research was the first since 2006 to have such a large and inclusive scope
on stand-alone benefit characteristics.
Previous data on stand-alone PDPs suggested minimal change in the PDP market from
2006 to 2009. It appeared there was a larger initial change in benefit offerings from 2006 to
2007, but subsequent data reports from 2008 and 2009 suggested that this was overly inflated.
The majority of the literature warranted simplification and standardization of Medicare Part D. A
lesser amount of research favors the fact that the market responded adequately to consumer
demand. This review of the literature helped to elicit the direction of the program and provided a
sense of what changes may have been beneficial to the program. This past research was
fragmented, noncomprehensive, and accumulative. This present study aimed to identify trends in
the PDP benefit design providing further evidence for or against the standardization and
simplification of Medicare Part D. In part, this current analysis underscored the role of the free
6

CMS defined the gap in coverage also known as the “doughnut hole” as the period of time in which Part D
enrollees were required to pay the full cost of their drugs until they qualified for catastrophic coverage, in which
case they would then be reimbursed for drug purchases again.
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market on Medicare Part D, but most importantly, the results provided a general direction for the
program and implicated certain policy changes.
Methods
Data on Medicare Part D from Centers for Medicare and Medicaid Services (CMS) was
available since January 2006. The following research focuses on the characteristics of standalone PDPs, as part of Part D. This research utilizes data on the characteristics of plan benefits
from the CMS “landscape” files. Centers for Medicare and Medicaid Services annually release
this file. It contains information on every state and every available stand-alone PDP.7 CMS
collected the data and released the “landscape” files in November of 2005, November of 2006,
September of 2007, and September of 2008. CMS’ plan finder and Kaiser Family Foundation
provided data verification in several instances. However, only the CMS landscape files contained
all data on PDP availability and Ohio enrollment for 2009. Kaiser Family Foundation provided
national enrollment data of PDPs for 2009. This information was also available through CMS.
Variables:
Using the four CMS landscape files, this research reports on the number of PDPs
available (dependent variable) with the specified benefit characteristics (independent variables)
of stand-alone PDPs in Ohio and the United States as a whole. This research presents summary
statistics on each of the following independent variables on a state and national level.
-

Type of Benefit
o The benefit type variable was either basic or enhanced. CMS established the
minimum benefits for PDPs annually. Basic PDPs offered the minimum
benefits established by CMS. Enhanced plans offered additional benefits.

7

This research focuses solely on stand-alone prescription drug plans. It does not include Medicare Advantage plans
nor does it include employer sponsored stand-alone PDPs.
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Some plans offered a different set of benefits that were actuarially equivalent
to basic PDPs. CMS regarded these plans as enhanced. When available, this
research separated the actuarially equivalent plans from the enhanced plans.

-

Low-Income Subsidy Plan Availability

-

Monthly premium amount

-

Deductible
o None, Less than Standard Deductible, or Standard Deductible

-

Type of drug coverage within the coverage gap
o None, Generics, Many Generics, Some Generics, Preferred Generics, and
Generics & Brands

This analysis examines PDP availability for each of these independent variables from
2006 through 2009 using the four aforementioned “landscape” files. This analysis demonstrates
the similarities and differences in availability from year to year along with a comparison between
the United States and Ohio. In addition, this research presents plans in Ohio with the highest
enrollment in 2009 along with the monthly premiums and the deductibles of these plans. Also,
this research compares the national sponsors with the highest enrollment to PDPs in Ohio with
the highest enrollment.8 All summary statistics, tables, and figures were created using Microsoft
Excel 2004.
Results
PDP Availability
Table 1 summarizes the distribution of stand-alone PDPs in the United States from 2006
to 2009. From 2006 to 2009, the number of PDPs nationwide ranged from a low of 1,429 in 2006
8

Enrollment data on stand-alone PDPs incorporated both individuals enrolled automatically as part of the LIS
program and individuals that enrolled in a stand-alone PDP, rather than a MA-PD plan or a plan with creditable
coverage.
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to a high of 1,875 in 2007. There was a 31% increase in available plans from 2006 to 2007. Plan
availability was relatively unchanged from 2007 to 2008. Subsequently, from 2008 to 2009, there
was a 7% decline in plan availability from 1,824 to 1,689. In comparing benefit design in 2006
and 2007, there was a 4% increase in PDPs with enhanced design in 2007 (from 43% to 47%).
CMS established PDPs as either basic or enhanced. PDPs that offered the standard benefit
design, as established by CMS annually, were termed basic. CMS classified all other PDPs as
enhanced. There were a proportion of enhanced plans that were actuarially equivalent to the
standard benefit design. Centers for Medicaid and Medicare Services deemed benefit designs
actuarially equivalent when their value was the same based on CMS’ actuarial assumptions.
Benefit design in 2008 and 2009 was not available.
Table 2 summarizes the distribution of PDPs in Ohio from 2006 to 2009. In Ohio the
number of available stand-alone PDPs between 2006 and 2009 ranged from a minimum of 43 in
2006 to a maximum of 60 in 2007. In 2008 and 2009, the amount of available plans declined.
There were 49 available plans in 2009. In terms of benefit type, the proportion of PDPs that offer
enhanced benefits increased from 2007 to 2009 (from 45% to 53% of available plans), although
the absolute number of plans in Ohio stayed about the same.
Tables 3 and 4 provide the sponsors with the highest national enrollment and the PDPs in
Ohio with highest enrollment in 2009, respectively. In 2009, 72% of beneficiaries enrolled in 10
PDPs, and 89% of beneficiaries enrolled in 20 PDPs. Nearly 23% of individuals in Ohio enrolled
in the AARP preferred plan sponsored by United Health Care. The PDP with the second highest
enrollment, Humana Enhanced, had only 9% of the market share. In 2009, only one of the ten
most highly enrolled PDPs in Ohio was not also one of the top enrolling sponsors nationally.
This PDP sponsored by First Health Part D carried 3% of the market share in Ohio. In 2009,
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organizations that offered at least one plan in all fifty states and the District of Columbia
sponsored 47 of the 49 PDPs in Ohio. UPMC and Bravo were the only two organizations not
available nationwide.
As shown in Table 5, after 2006, there was a steady decline in PDPs available for lowincome-subsidy (LIS) in the U.S. from 29% in 2006 to 18% in 2009.9 Table 6 demonstrates the
distribution of LIS PDPs. In 2009, the proportion of PDPs in Ohio available to LIS beneficiaries
was 12%. This demonstrates an 11% decline since 2006. The number of LIS plans has ranged
from a minimum of 6 in 2009 to a maximum of 22 in 2007.
PDP Premiums and Deductibles
Table 7 summarizes the distribution of stand-alone PDPs in the United States by monthly
premium from 2006 to 2009. In 2009, 76% of PDPs had premiums between $20 and $50. In
2006, 82% of PDPs had premiums between $20 and $50. The proportion of plans in 2009 with
above $60 was much larger compared to 2006. In 2006, 5% of plans had premiums above $60.
This percentage rose to 23% in 2009. The proportion of plans with premiums above $50
increased from 16% in 2006 to 30% in 2009. The average (unweighted by enrollment) monthly
premium in 2009 was $45.45 up from $37.43 in 2006.
Table 8 displays the premium distribution of stand-alone PDPs in Ohio. The majority of
premiums fall in the range of $20 to $50. In 2009, 69% of PDPs had premiums between $20 and
$50, and in 2006, 74% had premiums in that range. A higher proportion of plans in 2009 were in
the $60 to $100 range compared to 2006. The proportion of plans with premiums over $50
increased from 20% in 2006 to 29% in 2009. There were never any plans in Ohio with premiums

9

Medicare beneficiaries who qualified for full Medicaid benefits (dual eligibles), those enrolled in Medicare
Savings Programs (MSP), and those who received the Supplemental Security Income (SSI) were automatically
qualified for the LIS. Other beneficiaries qualified for full or partial subsides if they met certain income and asset
standards (KFF, 2008).
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over $100 per month. The average premium of PDPs increased between $8 and $10 since 2006.
In 2009, the average unweighted premium in Ohio is $44.33. Table 9 illustrates the premiums of
the most highly enrolled PDPs in Ohio. The average monthly premium of these plans is $32.47.
The monthly premium of the AARP enhanced plan was $38.20. This plan has a strong influence
on the weighted average premium because of it encompasses nearly one-fourth of the market
share.
As displayed in Table 10, the percentages of plans offering the standard deductible in the
U.S. were relatively unchanged since 2006. The standard deductible, indexed to grow annually
with per capita Part D spending, increased from $250 in 2006 to $295 in 2009. About a third of
all PDPs offered the standard deductible from 2006 through 2009. In 2009, the majority of PDPs
(56%) did not have a deductible, as was the majority in 2006 (58%). Additionally, there was only
a small change in the percentage of plans offering less than standard deductible (from 8% in
2006 to 11% in 2009).
Table 11 displays the distribution of PDPs in Ohio by deductible amount from 2006 to
2009. Ohio follows the same overall national trends with about a third of all PDPs offering the
standard deductible from 2006 through 2009. In 2009, the majority of PDPs (57 percent) did not
have a deductible, similar to 2006. Five percent of plans had a deductible lower than the standard
amount in 2009, compared to 3 percent in 2006. Table 12 lists the ten PDPs with the highest
enrollment in Ohio for 2009 with their corresponding deductible amount. Among these ten
PDPs, four have no deductible and five have the standard deductible.
PDP Gap Coverage
Since 2006, sponsors offered a mixture of different types of gap coverage including
covering all generics, covering few too many generics, and covering certain “preferred”
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generics.10 Table 13 demonstrates the national distribution of PDPs by type of gap coverage from
2006 to 2009. Since 2006, a 10% increase occurred in amount of plans offering some type of gap
coverage. In 2009, 24% of plans offered some coverage. Fourteen of the twenty four percent
covered the majority of generics during the coverage gap. There were only three plans in 2009
that covered any brand name drugs. These three plans covered only a small fraction of brand
name drugs. In 2006 and 2007, a larger share of the PDP market covered brand name drugs. In
general, since 2006, there was an overall decline in PDPs covering all generics during the gap. In
2009, only 6% of plans covered all generics during the gap.
Table 14 demonstrates the distribution of PDPs in Ohio by type of gap coverage from
2006 to 2009. The number of PDPs with any type of gap coverage increased from 7 in 2006 to
12 in 2009. This was an increase from 16% in 2006 to 24% of available plans in 2009. The only
PDPs that offered gap coverage in 2008 and 2009 offered generic-only coverage. In 2006 and
2007 one plan offered coverage of brand-name drugs. In 2009, none of the ten most popular
PDPs in Ohio offered gap coverage. Overall, only 7% of enrollees in Ohio enrolled in plans with
gap coverage. Figure 1 compares the average premium for plans by type of gap coverage. The
average monthly premium for plans with some type of gap coverage in 2009 is $67.50 compared
to a premium of $35.89 in plans without gap coverage.
Discussion
This analysis highlighted valuable information about the direction of Part D. From 2006
to 2009, the largest changes in Ohio occurred in overall PDP availability, plans available for
subsidy, and plans offering gap coverage. Additionally, from 2006 to 2009, there was a gradual
increase in the unweighted average monthly premium, but there were only minimal changes in
10

CMS defined gap coverage as the period of time in which Part D enrollees were required to pay the full cost of
their drugs until they qualified for catastrophic coverage. Sponsors began offering plans that helped mediate this
otherwise 100% out of pocket cost by offering varying degrees of gap coverage.
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the percentages of PDPs offering the standard deductible. Overall, this research identified the
same trends at the Ohio statewide level and the United States’ national levels.
PDP Availability
During the first two years of the program, surveys suggested the enrollment process was
too complicated and many beneficiaries desired simplification (KFF, 2006; Dulio, Perry, &
Cubanski, 2007). Despite this, in 2007, PDP availability increased in Ohio and on a national
level by 40 and 31 percent respectively. Availability remained unchanged in 2008. Additionally,
the results indicated a decline in availability from 2008 to 2009, however, there were still more
PDPs available in 2006 than in 2009. The decline from 2008 to 2009 suggests that the market
responded to beneficiary demand by dropping their unpopular plans. However, the only decline
in availability was from 2008 to 2009, which makes it difficult to conclude that this is a
definitive trend in the market.
Interestingly, from 2006 to 2009, the results demonstrate that PDP availability increased
for non-LIS beneficiaries. Since 2006, the proportion of PDPs eligible for LIS declined
significantly in both the U.S. and Ohio. Therefore, despite the overall decline in PDPs from 2008
to 2009, there was an increase in PDPs available to non-LIS beneficiaries. These results suggest
a lack of choice for non-LIS beneficiaries in both Ohio and on the national level. Previous survey
data suggests beneficiaries believe there are too many PDPs to choose from. Additionally,
previous research on human behavior suggests that beneficiaries are not capable of choosing
their individual best plan when faced with so many options. (Cummings & Rice, 2008; Dulio,
Perry, & Cubanski, 2007; Hibbard, Slovic, Peters et al., 2000; Hoadley, 2008; Iyenger,
Huberman, & Jiang, 2004; O’Brien & Hoadley, 2008; Schwartz, 2004; Scott, 2000).
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In Ohio 96% of beneficiaries enrolled in plans that were available to all beneficiaries
nationwide. The remaining 4% enrolled in plans only available to beneficiaries within the state
of Ohio. In 2008, Ohio had only two PDPs that were not available nationwide. Only one of these
plans carried noteworthy enrollment (3.6%) and ranking eighth in total Ohio enrollment. In Ohio,
72% of individuals enrolled in 10 of the 58 PDPs. One PDP in Ohio, the AARP Medicare
Preferred plan, captured 23% of the market share. These results reveal a PDP market dominated
by larger nationally run corporations perhaps with added advantages over smaller state run
organizations.11
PDP Premiums
The results illustrate a consistent increase in the average of prescription drug plan
premiums both statewide in Ohio and on the national level since 2006.12 The results also show
that the average premium of the most popular PDPs in Ohio (accounting for 2/3 of enrollees) was
significantly lower than the average of all PDPs in 2009. These results suggest that beneficiaries
enrolled in plans with lower premiums. National studies also demonstrated that beneficiaries
chose plans with lower premiums more frequently (Hoadley, Hargrave et al., 2006). Based on
these findings, beneficiaries continue to demand and enroll in plans with lower premiums despite
sponsors offering increasingly more plans with higher premiums. Previous studies examined this
discrepancy and concluded that beneficiaries focus on monthly premium over other benefit
characteristics (Gold, Achman, & Brown, 2003).
PDP Gap Coverage
The percentage of plans offering gap coverage increased 10% over the past four years in
Ohio and the U.S. Despite this, 93% of individuals in Ohio enrolled in plans without gap
11

12

This idea is also known as economies of scale.
The health care inflation rate for 2006 was 6.7% and in 2007 it was 6.1% (Hartman et al, 2007)
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coverage—a figure unchanged since 2006 (Hoadley, Hargrave et al., 2006). Contrary to
enrollment data, previous surveys suggested an overwhelming desire for increased coverage
during the coverage gap (Dulio, Perry, & Cubanski, 2007). Previous studies also demonstrated
that adherence to medications declines during the coverage gap (Yin, Basu et al., 2008;
Lichtenberg, Frank, & Sun, 2007; Madden, Graves et al. 2008). In this example, it seems the
PDP market responded to both consumer desire and consumer need, but consumers appeared
disinterested in plans with gap coverage. Results reveal that PDPs with gap coverage have
significantly higher monthly premiums than plans without. This increase in premium could be
one reason why sponsors have not seen more beneficiaries enrolled in PDPs with gap coverage.
As previously mentioned, Gold, Achman, & Brown (2003) suggest this to be the case.
Policy Implications
Both survey data and research on human behavior recognized a benefit to beneficiaries
choosing from a limited number of PDPs (Hibbard & Peters, 2003; Iyengar & Lepper, 2000;
Mobley, McCormack, & Wang, 2005). The results of this current study demonstrated that since
2006, PDP availability increased for beneficiaries who did not participate in auto-enrollment.
Based on this finding, it would be beneficial for CMS to consider methods limiting the number
of choices to beneficiaries. It would also be beneficial to simplify the selection process in a
manner that allows for optimal plan selection. In 2008, CMS allowed beneficiaries to sort plans
based upon gap coverage, annual deductible, drug cost sharing, summary rating of PDP quality
(customer satisfaction rating), national availability, formulary, and coverage of brand name
medications. This provides opportunity for individuals to simplify their available choices,
however, this analysis and previous research suggest that beneficiaries placed a heavy priority on
choosing a plan with a low premium and one that was available nationwide. As a result, CMS

PDP Landscape

26

may want to consider different modes of simplification whereby beneficiaries incorporate other
benefit characteristics into the decision making process.
CMS and policymakers should consider continued promotion of plans that offer coverage
during the gap. The literature suggests that during the coverage gap beneficiaries skip doses,
choose not to refill medications, and self-prescribe in ways that are not conducive to their health
(Yin, Basu et al., 2008; Lichtenberg, Frank, & Sun, 2007; Madden, Graves et al., 2008). Previous
research also suggests that these habits may cause increased costs to Medicare A and B by
increasing disease exacerbations and hospitalizations (Yin, Basu et al., 2008; Lichtenberg, Frank,
& Sun, 2007; Madden, Graves et al., 2008). More importantly, previous surveys suggested that
many more than the 5-7% of beneficiaries in PDPs with gap coverage wish to be in plans with
coverage during the gap (KFF, 2008). Policymakers should consider the low enrollment in PDPs
offering gap coverage as problematic and as an opportunity where Part D can be improved.
Future research should also continue to examine the effect of this gap in coverage.
Previous research has not identified an association between the quality of the PDP and
monthly premium, so it is unknown if choosing a plan with the lowest monthly premium is
beneficial to beneficiaries. However, typically the increase in monthly premium dictates an
increase in coverage. As mentioned, an absence of coverage during the gap often necessitates
poor compliance with prescription medications (Yin, Basu et al., 2008; Lichtenberg, Frank, &
Sun, 2007; Madden, Graves et al., 2008). Based on this research, it appears unlikely that
choosing a plan with the lowest premium is a prudent selection. Future research examining
monthly premium as a predictor of beneficiary enrollment is important for future policymaking
decisions. Using enrollment data from 2006 through 2009, researchers need to identify which
benefit characteristics have the strongest association with enrollment. In addition, researchers
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should look for associations between enrollment and formulary, customer satisfaction, gap
coverage, deductible, LIS, and nationwide availability. These associations will provide further
insight into which factors are most important to beneficiary plan choice. Finally, future research
should examine which factors, besides coverage during the gap, positively or negatively affect
health outcomes. Then, policymakers will be able to reinforce systems that do not allow
beneficiaries to make decisions based on superfluous factors.

Limitations
This current study has a number of limitations. First, the nature of this data does not
allow one to determine causality. Second, complete enrollment data was unavailable. By
obtaining state enrollment in Ohio along with national enrollment from 2006 through 2009, more
clearly defined relationships and trends could be identified. It would also be advantageous to
have individual enrollment data to help identify which plans beneficiaries choose to switch to
and from. Third, it took a longer than expected amount of time to sort through the raw data. If
more time were available, other benefit characteristics could be analyzed. The exclusion of
formulary and customer satisfaction as variables are recognized limitations. Researchers
hypothesized that a significant factor in beneficiary choice was based on which brand name
medications were included on the plan’s formulary. Fortunately, this previous research supplies a
template whereby one identifies how many of the ten most prescribed brand-name medications
are on each PDP’s formulary. Using this information, a researcher could correlate enrollment
with number of medications on the formulary. Preliminary data reveals that plans with higher
enrollment often list all ten of the most prescribed medications on their formulary. Researchers
could use a similar model for customer satisfaction ratings. Despite this limitation, the

PDP Landscape

28

conclusions about the studied variables are still noteworthy. It should just be noted that this
analysis does not include all factors that influence the decision to enroll in a specific PDP. It
should also be mentioned that previous national studies support the same trends identified in this
current study. So despite its limitations, this current study replicated the findings of previous
studies.

Conclusions
This current research hypothesized that the smaller market of Ohio would reflect changes
and trends in benefit characteristics not seen on the national level due to its size. However, this
research identified the same state trends also observed nationally. The striking similarities
between the U.S. and Ohio are likely a product of national sponsorship dominating the market. In
general, the similarities between Ohio and the U.S. suggest that conclusions made about Ohio’s
enrollment in 2009 are applicable nationally.
This research provides a cumulative and comprehensive view of the PDP market. There
are several key conclusions based on the snapshots and comparisons of benefit characteristics.
Despite the overall decline in PDP availability from 2008 to 2009, the evidence shows that PDP
availability is increasing for beneficiaries that do not enroll in LIS PDPs. Evidence also suggests
that beneficiaries are choosing to enroll in PDPs with the lowest monthly premium. This appears
to be an important factor in the process of choosing a PDP.
In concluding, it is important to discuss the general direction of Medicare Part D. This
current analysis revealed that a small number of national sponsors dominated the market, and
one PDP controlled 23% of the market share. While, sponsors continued to offer more plans with
gap coverage, 93% of beneficiaries enrolled in plans without gap coverage. Previous research on
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patient adherence to prescription medications suggests that beneficiaries need to enroll in plans
that offer coverage during the gap. So, in general, this analysis demonstrated that market forces
might be capable of responding in a fashion that best serves Medicare beneficiaries, but this can
only occur when beneficiaries choose optimally. Currently, there is no evidence to suggest that
the process has led beneficiaries to choose the utility maximizing plan.
Based on previous and this current research, there is still some uncertainty which
direction the free market model will drive Part D. The only evidence of simplification was the
decline in overall availability from 2008 to 2009. So, to state this decline implies simplification
would simply be incorrect. In the future, it is imperative that policymakers and CMS continue to
evaluate the enrollment process to ensure that the assumptions behind The Rational Choice
Theory are being met. In the end, policymakers must realize that the aim of Part D is to improve
health outcomes for beneficiaries, and if future research suggests that beneficiaries are not
choosing plans that promote health, the program should be re-evaluated.
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Appendix

Table 1
Distribution of stand-alone PDPs in U.S., by type of benefit, 2006-2009
2006 Plans
2007 Plans
2008 Plans 2009 Plans
Benefit Type Number
Percent
Number
Percent Number
Number
Basic
132
9.2%
228
12.2%
n/a
n/a
Actuarially
689
48.2%
760
40.5%
n/a
n/a
Equivalenta
Enhanced
608
42.5%
887
47.3%
n/a
n/a
Total
1429
100.0%
1875 100.0%
1824
1689
Note. In 2008 and 2009, the benefit type of PDPs was not easily identified and therefore excluded. This information is in the
CMS landscape files. a CMS establishes a standard benefit design annually. CMS allowed sponsors to offer PDPs that were
actuarially equivalent to the basic plans. Sponsors could also offer PDPs with an increase in benefits. CMS determined what
benefits were actuarially equivalent. One can obtain these actuary tables through CMS.

Table 2
Distribution of stand-alone PDPs in Ohio, by type of benefit, 2006-2009
2006
Plans
Benefit
Type
Basic
Enhanced
Total

Number
n/a
n/a
43

2007 Plans
Number
33
27
60

Percent
55.0%
45.0%
100.0%

2008 Plans
Number
29
29
58

Note. In 2006, the benefit type of PDPs was unable to be found.

Percent
50.0%
50.0%
100.0%

2009 Plans
Number
23
26
49

Percent
46.9%
53.1%
100.0%
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Table 3
PDP Offerings among sponsors with highest enrollment nationally in 2009
Organization Name
Humana
Humana
Humana
United Health Care
United Health Care
United Health Care
United Health Care
Universal American
Universal American
Universal American
WellCare
WellCare
UniCare
SilverScript Insurance Co.
SilverScript Insurance Co.
SilverScript Insurance Co.
Anthem Blue Cross and
Blue Shield
Anthem Blue Cross and
Blue Shield
Anthem Blue Cross and
Blue Shield
Health Net
Health Net
RxAmerica
RxAmerica

Plan Name
Humana PDP Complete
Humana PDP Enhanced a
Humana PDP Standard a
AARP MedicareRx Preferred
AARP MedicareRx
Enhanced
AARP MedicareRx Saver a
United Health Rx Basic
Community CCRx Basic a
Community CCRx Choice
Community CCRx Gold
WellCare Classic a
WellCare Signature
MedicareRx Rewards
Standard
SilverScript Complete
SilverScript Plus
SilverScript Value a
Blue MedicareRx Plus
Blue MedicareRx Premier
Blue Medicare Rx Value a
Health Net Orange Option 1
Health Net Value Orange
Option 2
Advantage Freedom Plan by
RxAmerica
Advantage Star Plan by
RxAmerica

Note: Enrollment data on national sponsors found through Kaiser Family Foundation.
ten most highly enrolled PDPs in Ohio

a

Denotes a PDP in the top
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Table 4
Most highly enrolled stand-alone PDPs Ohio and corresponding sponsor in 2009
Enrollment
Organization Name
Plan Name
United Health Care
AARP MedicareRx Preferred
119642
Humana Insurance Company
Humana PDP Enhanced
47428
Universal American
Community CCRx Basic
45890
Humana Insurance Company
Humana PDP Standard
31436
SilverScript Insurance Company
SilverScript Value
29426
Anthem Blue Cross and Blue Shield
Blue MedicareRx Value
26171
WellCare
WellCare Classic
25064
First Health Part D-Premier b
18997
First Health Part D
WellCare
WellCare Signature
15804
United Health Care
AARP MedicareRx Saver
13963

Percentage of
Total Enrollment
22.7%
9.0%
8.7%
6.0%
5.6%
5.0%
4.8%
3.6%
3.0%
2.6%

Note. Enrollment data obtained through CMS. b Denotes only plan in Ohio’s top enrolled PDPs that is not in top nationally
enrolled PDPs

Table 5
Distribution of stand-alone PDPs in the U.S., by eligibility for enrollment of low-income subsidy beneficiaries for
zero premium, 2006-2009
2006 Plans
Eligible for
Subsidy
Yes
Yes, with
premium waiver
No
Total

2007 Plans

2008 Plans

2009 Plans

409

Percent
28.6%

Number
483

Percent
25.7%

Number
442

Percent
24.2%

Number a
~304

Percent b
18%

1020
1429

71.4%
100.0%

157
1235
1875

8.4%
65.9%
100.0%

53
1329
1824

2.9%
72.9%
100.0%

~1385
1689

82%
100%

Number

a

In 2009, the number of PDPs with LIS subsidy was based on percentages provided by Kaiser Family Foundation.
Approximations are denoted by ~. b Percentages were not provided to the tenth decimal place as is written in other tables. c A
CMS policy put in place in 2007 allowed LIS beneficiaries that were alredy enrolled in a PDP to stay in that plan in 2007 if the
monthly premium exceeded the low-income benchmark by no more than $2. In 2009, it is unknown how many PDPs fell into this
group.

Table 6
Distribution of stand-alone PDPs in Ohio, by eligibility for enrollment of low-income subsidy beneficiaries for zero
premium, 2006-2009
2006 Plans
Eligible for
Subsidy
Yes
No
Total

Number
10
33
43

Percent
23.3%
76.7%
100.0%

2007 Plans
Number
22
38
60

Percent
36.7%
63.3%
100.0%

2008 Plans
Number
15
43
58

Percent
25.9%
74.1%
100.0%

2009 Plans
Number
6
43
49

Percent
12.2%
87.8%
100.0%
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Table 7
Distribution of stand-alone PDPs in U.S., by monthly premium, 2006-2009
2006 Plans
2007 Plans
2008 Plans
Monthly Premium
Number
Percent
Number
Percent
Number
Percent
Under $20
90
6.3%
104
5.5%
132
7.2%
$20-$30
313
21.9%
619
33.0%
613
33.6%
$30-$40
459
32.1%
503
26.8%
385
21.1%
$40-$50
334
23.4%
432
23.0%
298
16.3%
$50-$60
160
11.2%
74
3.9%
63
3.5%
$60 and up
73
5.1%
143
7.6%
333
18.3%
Total
1429
100.0%
1875
100.0%
1824
100.0%

2009 Plans
Number
Percent
58
3.4%
322
19.1%
496
29.4%
313
18.5%
115
6.8%
385
22.8%
1689
100.0%

Table 8
Distribution of stand-alone PDPs in Ohio, by monthly premiums, 2006-2009
Monthly Premium
Under $20
$20-$30
$30-$40
$40-$50
$50-$60
$60 and up
Total

2006 Plans
Number
Percent
3
7.0%
10
23.3%
13
30.2%
9
20.9%
6
13.9%
2
4.7%
43
100.0%

2007 Plans
Number
Percent
2
3.3%
21
35.0%
16
26.7%
14
23.3%
3
5.0%
4
6.7%
60
100.0%

Table 9
Premiums of plans in 2009 with highest enrollment in Ohio
Organization Name
Plan Name
UnitedHealthcare
AARP MedicareRx Preferred

2008 Plans
Number
Percent
2
3.5%
20
34.5%
14
24.1%
11
19.0%
1
1.7%
10
17.2%
58
100.0%

Premium
$38.20

Humana Insurance Company

Humana PDP Enhanced

$39.50

Universal American
Humana Insurance Company

Community CCRx Basic
Humana PDP Standard

$27.90
$42.70

SilverScript Insurance Company
Anthem Blue Cross and Blue Shield

SilverScript Value
Blue MedicareRx Value

$25.10
$32.00

WellCare
First Health Part D

WellCare Classic
First Health Part D-Premier b

$37.00
$23.00

WellCare
UnitedHealthcare

WellCare Signature
AARP MedicareRx Saver

$33.50
$25.80

Note: b Denotes only plan in Ohio’s top enrolled PDPs that is not in top nationally enrolled PDPs

2009 Plans
Number
Percent
1
2.0%
10
20.4%
14
28.6%
10
20.4%
3
6.1%
11
22.5%
49
100.0%
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Table 10
Distribution of stand-alone PDPs in U.S., by deductible amount, 2006-2009

Deductible
None
Less than Standard Deductible
Standard Deductible
Total

2006 Plans
Number Percent
834
58.4%
112
7.8%
483
33.8%
1429 100.0%

2007 Plans
Number Percent
1127
60.1%
157
8.4%
591
31.5%
1875 100.0%

2008 Plans
Number Percent
1069
58.6%
148
8.1%
607
33.3%
1824 100.0%

2009 Plans
Number Percent
939
55.6%
186
11.0%
564
33.4%
1689 100.0%

Note. Standard deductible as follows: $250 in 2006, $265 in 2007, $275 in 2008, and $295 in 2009

Table 11
Distribution of stand-alone PDPs in Ohio, by deductible amount, 2006-2009
2006 Plans
2007 Plans
2008 Plans
Deductible
Number Percent Number Percent Number Percent
None
25
58.1%
38
63.4%
34
58.6%
Less than Standard Deductible
3
7.0%
5
8.3%
4
6.9%
Standard Deductible
15
34.9%
17
28.3%
20
34.5%
Total
43 100.0%
60 100.0%
58 100.0%
Note. Standard deductible as follows: $250 in 2006, $265 in 2007, $275 in 2008, and $295 in 2009

Table 12
Deductible amount of ten PDPs with highest enrollment in Ohio, 2009
Organization Name
Plan Name
UnitedHealthcare
AARP MedicareRx Preferred

Deductible
$0

Humana Insurance Company

Humana PDP Enhanced

$295

Universal American
Humana Insurance Company

Community CCRx Basic
Humana PDP Standard

$295
$295

SilverScript Insurance Company
Anthem Blue Cross and Blue Shield

SilverScript Value
Blue MedicareRx Value

$130
$295

WellCare
First Health Part D

WellCare Classic
First Health Part D-Premier b

WellCare
UnitedHealthcare

WellCare Signature
AARP MedicareRx Saver

$0
$0
$295
$0

Note: b Denotes only plan in Ohio’s top enrolled PDPs that is not in top nationally enrolled PDPs

2009 Plans
Number Percent
28
57.1%
5
10.2%
16
32.7%
49 100.0%
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Table 13
Distribution of stand-alone PDPs in U.S. by type of coverage in the gap, 2006-2009
2006 Plans
2007 Plans
2008 Plans
Gap Coverage
None
Generics
Many Generics (>65%)
Some Generics (10-64%)
"Few" brand name drugs
Generics & Brands
Total

b

Number
1209
187

Percent
84.6%
13.1%

Number
1337
511

Percent
71.3%
27.3%

2009 Plans
c

Number
~1295
~255

Percent
71%
14%

~274

15%

Number
~1266
~101
~236
~83

Percent c
75%
6%
14%
5%

3

0.2%

1689

100%

a

33
1429

2.3%
100.0%

27
1875

1.4%
100.0%

1824

100%

a

“Few” brand name drugs is defined as less than 10% of brand name drugs on the formulary. b Of the 27 PDPs in 2007 covering
brand-name drugs in the coverage gap, 25 cover all formulary drugs and 2 cover brands and preferred generics. The assumption
is that in 2006, the 33 PDPs covering generics and brand-name drugs covered all generics and an unidentified amount of brandnamed drugs. c Data from 2008 and 2009, the number of PDPs offering varying types of gap coverage from 2008 and 2009 was
based on percentages provided by KFF. Approximations are denoted by ~. Percentages were not provided to the tenth decimal
place as is written in other tables.

Table 14
Distribution of stand-alone PDPs in Ohio, by type of coverage in the gap, 2006-2009
2006 Plans
2007 Plans
2008 Plans
Type of Gap Coverage
Number Percent
Number Percent Number Percent
None
36
83.70%
43
71.6%
41
70.7%
Generics
6
14.00%
16
26.7%
9
15.5%
Many Generics (>65%)
Some Generics (10-64%)
2
3.5%
All Preferred Generics
6
10.3%
Generics & Brands
1
2.30%
1
1.7%
Total
43 100.00%
60 100.0%
58 100.0%

2009 Plans
Number Percent
37
75.5%
3
6.1%
7
14.3%
2
4.1%

49

100.0%
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Figure 1: Average monthly unweighted premiums for all PDPs in Ohio by type of gap coverage, 2009
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Glossary

MMA – Medicare Modernization Act of 2003
PDP – Prescription Drug Plan
CMS – Centers for Medicaid and Medicare Services
Dual eligibles - Beneficiaries eligible for both Medicare and Medicaid have become known as
dual eligibles.
Creditable coverage - The voluntary enrollment process provides beneficiaries the option to
enroll in either a MA-PD plan, stand-alone PDP, or from another source that maintains a
minimum coverage standard established by CMS (known as creditable coverage).
Benchmark plan – Plans having only the basic benefit characteristics as established by CMS and
also eligible to LIS beneficiaries.
KFF – Kaiser Family Foundation
LIS – Low-Income Subsidy
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Public Health Competencies Achieved:
Domain #1: Analytic Assessment Skill
-

Defined a problem
Identified relevant and appropriate data and quality sources of information
Evaluated the integrity and comparability of data and identified the gaps in the data
Recognized how the data illuminated ethical, political, scientific, economic, and
overall public health issues

Domain #2: Policy Development/Program Planning Skills
-

Collected, summarized, and interpreted information on a relevant issue
Articulated the health, fiscal, administrative, legal, social, and political implications
of each policy option
Stated the feasibility and expected outcomes of each policy option

Domain #3: Communication Skills
-

Communicated effectively both in writing and orally
Effectively presented accurate demographic, statistical, programmatic, and scientific
information for professional and lay audiences
Listened to others in an unbiased manner, respected the points of view of others, and
promoted the expression of diverse opinions and perspectives

Domain #5: Community Dimensions of Practice Skills
-

Described the role of government in the delivery of community health services

Domain #6: Basic Public Health Sciences Skills
-

-

Identified the individual’s and organization’s responsible within the context of the
Essential Public Health Services and core functions
Defined, assessed, and the health status of populations, determinants of health and
illness, factors contributing to health promotion and disease prevention, and factors
influencing the use of health services
Understood the historical development, structure, and interaction of public health and
health care systems
Identified and applied basic research methods used in public health
Identified and retrieved current relevant scientific evidence
Identified the limitations of research and the importance of observations and
interrelationships
Developed a lifelong commitment to rigorous critical thinking

List of public health competencies obtained from the “Competencies Project” at
http://trainingfinder.org/competencies/list_levels.htm

